Laryngeal stenosis is a congenital or acquired narrowing of the airway that may affect the supraglottis, glottis, and/or subglottis. It can be defined as a partial or circumferential narrowing of the endolaryngeal airway and may be congenital or acquired.
In most cases, laryngomalacia in infants is not a serious condition; they may feed and develop despite their loud breathing.
For these infants, laryngomalacia will resolve without surgery by the time they are 18 to 20 months old. Even though surgery-based treatment is unadvisable, laser treatment is highly recommended in reverse.
For that specific reason, several laser devices are being employed with such issues but not all of them proved to be well-functioning and efficient enough.
The FDA Portable 980nm Surgery Laser System SIFLASER-1.2B, however, has proved to be highly effective while treating such a disease.
The tissue components haemoglobin and melanin interact more with the blue laser light even at reduced power. Accordingly, this allows SIFLASER-1.2B to perform better and softer airway-opening laser surgeries to improve your breathing.
Further, the device can be appropriate for all Congenital medical applications including Congenital tumor removals because of its improved cutting performance.
What also makes the SIFLASER-1.2B highly recommended by surgeons is that it displays an accurate alignment and exact sighting during the surgery. All thanks to its green aiming beam.
To guarantee better results, the device is supported with a fibre guide laser.
First, it is compatible with various endoscopic uses. Second, these special fibres are sterilisable which, in turn, prevents any possible cross-infection while guaranteeing a clean and bloodless operative area.
That actually reduces the thermal damage and its peculiar interaction with haemoglobin.
Additionally, the complete absence of water absorption helps drastically reduce the overheating of the surrounding tissues. This should further reinforce the laser treatment’s efficacy.
Due to all these features and more, the SIFLASER-1.2 B guarantees increased cutting effectiveness, much higher than the one obtained with infrared lasers.
Since their invention, laser applications have expanded rapidly as they proved to be a successful addition to Congenital Larynx Stenosis surgeries.
In this article, we discuss the merits of laser therapy and precisely the efficacy of SIFLASER-1.2B as a modern surgical laser device in the treatment of Congenital Larynx Stenosis.
reference: Laryngeal stenosis following carbon dioxide laser in subglottic hemangioma. Report of three cases
Disclaimer: Although the information we provide is used by different doctors and medical staff to perform their procedures and clinical applications, the information contained in this article is for consideration only. SIFSOF is not responsible neither for the misuse of the device nor for the wrong or random generalizability of the device in all clinical applications or procedures mentioned in our articles. Users must have the proper training and skills to perform the procedure with each Laser System.
The products mentioned in this article are only for sale to medical staff (doctors, nurses, certified practitioners, etc.) or to private users assisted by or under the supervision of a medical professional.